Literature DB >> 18703433

Medical liability insurance as a barrier to the provision of abortion services in family medicine.

Christine E Dehlendorf1, Kevin Grumbach.   

Abstract

Family physicians who wish to provide abortions have been subject to both denial of coverage by medical liability insurers and the imposition of large premium increases. These policy decisions by insurance companies raise questions about the role of family physicians in abortion care and about the autonomy of medical specialties in defining their scope of practice. We review the issues specific to abortion services in the primary care setting and examine the broader implications for the medical profession. Finally, we review how advocacy and improved regulation of the insurance industry could help to ensure that clinicians who are trained and willing to provide services to their patients are not limited by the decisions of medical liability insurers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703433      PMCID: PMC2636480          DOI: 10.2105/AJPH.2008.136325

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  22 in total

1.  New research abortion training as an integral part of residency training.

Authors:  Ruth Lesnewski; Linda Prine; Marji Gold
Journal:  Fam Med       Date:  2003-06       Impact factor: 1.756

2.  Medication abortion and family physicians' scope of practice.

Authors:  Linda W Prine; Ruth Lesnewski
Journal:  J Am Board Fam Pract       Date:  2005 Jul-Aug

3.  Unintended pregnancy in the United States.

Authors:  S K Henshaw
Journal:  Fam Plann Perspect       Date:  1998 Jan-Feb

4.  Willing and able? Provision of medication for abortion by future internists.

Authors:  Eleanor Bimla Schwarz; Anne Luetkemeyer; Diana Greene Foster; Tracy A Weitz; Deborah Lindes; Felicia H Stewart
Journal:  Womens Health Issues       Date:  2005 Jan-Feb

5.  Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.

Authors:  E A Schaff; S H Eisinger; L S Stadalius; P Franks; B Z Gore; S Poppema
Journal:  Contraception       Date:  1999-01       Impact factor: 3.375

6.  Safety of mifepristone abortions in clinical use.

Authors:  Jillian T Henderson; Ann C Hwang; Cynthia C Harper; Felicia H Stewart
Journal:  Contraception       Date:  2005-09       Impact factor: 3.375

7.  Complications of first-trimester abortion: a report of 170,000 cases.

Authors:  E Hakim-Elahi; H M Tovell; M S Burnhill
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

8.  Manual vacuum aspiration for first-trimester abortion.

Authors:  J M Westfall; A Sophocles; H Burggraf; S Ellis
Journal:  Arch Fam Med       Date:  1998 Nov-Dec

9.  Risk factors for legal induced abortion-related mortality in the United States.

Authors:  Linda A Bartlett; Cynthia J Berg; Holly B Shulman; Suzanne B Zane; Clarice A Green; Sara Whitehead; Hani K Atrash
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

10.  Medical abortion in family practice: a case series.

Authors:  Linda Prine; Ruth Lesnewski; Nancy Berley; Marji Gold
Journal:  J Am Board Fam Pract       Date:  2003 Jul-Aug
View more
  5 in total

1.  Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.

Authors:  Karen Pazol; Andreea A Creanga; Suzanne B Zane
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Paradigm shift: moving toward access in every office.

Authors:  Margaret E Johnson Baylson
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

3.  Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice.

Authors:  Cameron Page; Sarah Stumbar; Marji Gold
Journal:  J Gen Intern Med       Date:  2012-01-06       Impact factor: 5.128

4.  Interest in Medication and Aspiration Abortion Training among Colorado Nurse Practitioners, Nurse Midwives, and Physician Assistants.

Authors:  Kate Coleman-Minahan; Jeanelle Sheeder; Jaron Arbet; Monica R McLemore
Journal:  Womens Health Issues       Date:  2020-04-22

5.  Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.

Authors:  Na'amah Razon; Sarah Wulf; Citlali Perez; Sarah McNeil; Lisa Maldonado; Alison Byrne Fields; Diana Carvajal; Rachel Logan; Christine Dehlendorf
Journal:  Contraception       Date:  2022-02-04       Impact factor: 3.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.